Efficacy and safety of Wangbi capsule for lumbar disc herniation
Li Haoxuan
Wang Linjie
Niu Ya'nan
Zheng Wenkui
Guo Zhao
Ma Xiaoyong
Zhang Xiong
Zhou Xiaozhe
Yan Huiqian
Gao Wenshan
Abstract:Objective This study aimed to investigate the efficacy and safety of Wangbi capsule for lumbar disc herniation.Methods A total of 146 patients with lumbar disc herniation treated in the Affiliated Hospital of Hebei University from Jan-uary 2022 to January 2023 were randomly assigned to control(77 cases)and study groups(69 cases).The control group was treated with Yaobitong capsule,and the study group with Wangbi capsule.Pain[Visual analogue scale(VAS)],func-tional impairment[Oswestry disability index(ODI)],and spinal function[Japanese Orthopaedic Association(JOA)]and lumbar activity were assessed before treatment and at 2 and 4 weeks after medication.Clinical efficacy,TCM syndrome im-provement,and safety were also evaluated.The study group was further assigned to three subgroups based on disease sever-ity:mild(JOA>20,25 cases),moderate(JOA scores from 11 to 20,24 cases),and severe(JOA≤10,20 cases).Their clinical efficacy,TCM syndrome scores,and adverse events were compared.Results At 2 and 4 weeks post-medication,the study group showed significantly lower VAS and ODI scores and higher JOA scores and lumbar activity than the control group(P<0.05).The overall response rate was similar between the two groups(P>0.05).Comparison of clinical efficacy and TCM syndrome scores among subgroups revealed statistically significant differences in overall response rates between the mild,moderate,and severe groups(P<0.05).However,no significant difference was observed between the mild and moderate groups(P>0.05).Two adverse reactions occurred in the study group and one in the control group.Conclusion The Wangbi capsule is ef-fective for mild and moderate lumbar disc herniation,alleviating pain,improving spinal function,and increasing lumbar activity,with good safety and tolerability profiles,which merits clinical application.
Keywords:Wangbi capsuleYaobitong capsuleLumbar disc herniationEfficacySafetyAdverse reactions
Publication Date:2024-11-20
Online Publishing Date:2025-08-15(First online date of this platform, not the publication date of the document)
Pages:7( 88-94 )
